Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for early clinical recognition. Supplemental oxygen therapy in fibrotic ILD ...

New Orleans, LA - Dr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward Fogarty, at the University of North Dakota School ...

Patients with fibrosing interstitial lung disease (ILD) who began supplemental oxygen therapy had triple the per patient per month ILD-related health care costs compared with those who did not.

SAN ANTONIO--(BUSINESS WIRE)--Turn Medical, a medical device company founded by passionate people committed to delivering innovative solutions, has launched its first product, a prone positioning ...